tiprankstipranks
Amicus Therapeutics (GB:0HF9)
LSE:0HF9
Holding GB:0HF9?
Track your performance easily

Amicus (0HF9) Financial Statements

0 Followers

Amicus Financial Overview

Amicus's market cap is currently ―. The company's EPS TTM is $-0.348; its P/E ratio is -28.19; Amicus is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 141.52M$ 126.67M$ 110.40M$ 115.08M$ 103.50M
Gross Profit$ 128.24M$ 115.41M$ 96.84M$ 103.76M$ 93.56M
EBIT$ 18.89M$ 12.05M$ -31.15M$ -18.83M$ -12.44M
EBITDA$ 21.64M$ 14.79M$ -28.46M$ -16.65M$ -9.49M
Net Income Common Stockholders$ -6.73M$ -15.70M$ -48.42M$ -33.84M$ -21.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 249.76M$ 260.06M$ 239.60M$ 286.20M$ 280.30M
Total Assets$ 786.56M$ 749.48M$ 721.79M$ 777.88M$ 764.08M
Total Debt$ 444.66M$ 444.06M$ 444.49M$ 445.06M$ 454.29M
Net Debt$ 194.90M$ 184.00M$ 204.89M$ 158.86M$ 173.99M
Total Liabilities$ 607.73M$ 616.96M$ 591.10M$ 617.71M$ 630.85M
Stockholders Equity$ 178.82M$ 180.71M$ 130.69M$ 160.17M$ 133.24M
Cash Flow-
Free Cash Flow$ -23.33M$ 21.59M$ -31.51M$ 1.73M$ -39.91M
Operating Cash Flow$ -22.97M$ 22.69M$ -29.70M$ 3.46M$ -38.35M
Investing Cash Flow$ 34.27M$ -21.98M$ 7.54M$ -23.96M$ 35.77M
Financing Cash Flow$ 18.19M$ -857.00K$ -13.31M$ 8.21M$ 37.62M
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis